Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Merck is recalling approximately 276,000 bottles of Temodar and Temozolomide capsules because cracked caps may fail to keep young children from accessing the medication.
GSK is recalling Panadol Advance pain relievers sold in Puerto Rico because the bottles do not meet child-resistant closure requirements.
Novartis is recalling Triaminic and Theraflu syrups because child-resistant caps may fail, posing a poisoning risk to children.
Rugby Children's Pain & Fever Concentrated Drops are recalled because the dispensing dropper lacks child-resistant packaging, posing a risk of accidental overdose.
Procter & Gamble is recalling Vicks Dayquil Cold & Flu Liquicaps because the packaging failed to meet child-resistant closure requirements.
Lex Pharmaceutical is recalling approximately 25,000 bottles of vitamins and medicines because they lack required child-resistant packaging, posing a poisoning risk to children.
PL Development is recalling 3,798 bottles of CVS Sleep Caplets because they lack required child-resistant packaging, posing a poisoning risk to children.
Revco is recalling approximately 7,000 bottles of Revco Brand Pain Reliever because they were not packaged in child-resistant containers as required by law.
Moore Medical is recalling 11,000 bottles of Valumed Diphenhydramine Hydrochloride capsules because they lack required child-resistant closures, posing a poisoning risk to children.
Armour Pharmaceutical is replacing child-resistant caps on thyroid tablets because some adults could not properly close them, posing a poisoning risk to children.
Bristol Myers is substituting Excedrin analgesic tablets because packages failed to meet federal child-resistant regulations. The recall covers 225 and 375 tablet sizes distributed nationwide prior to April 1977.